2474-2475 / 2953
Survival better than anticipated at trial inception in 2005
–
In M0, control arm patients
Effect of RT in N0M0 patients consistent with effect seen in previous large RCTs
Effect of RT in N+ patients similar to effect in N0 patients
Conclusions
Strongly supports routine use RT in node-positive prostate cancer
–
How best to administer?
ND James et al Proc ASTRO 2014.